Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case‐control studies from 27 countries
David I. Conway(University of Glasgow), Lorenzo Richiardi(Harvard University), Dana Mateș(National Institute of Public Health), Alex D. McMahon(University of Glasgow), Mark P. Purdue(Government of the United States of America), Gypsyamber DʼSouza(Johns Hopkins University), Valeria Edefonti(University of Milan), Luigino Dal Maso(Centro di Riferimento Oncologico), Antonio Agudo(Institut Català d'Oncologia), Darren R. Brenner(University of Calgary), Wolfgang Ahrens(Leibniz Institute for Prevention Research and Epidemiology - BIPS), Ana Menezes(Universidade Federal de Pelotas), Ivana Holcátová(Charles University), Silvia Franceschi(Centro di Riferimento Oncologico), Richard B. Hayes(New York University), Michael D. McClean(Boston University), José F. de Gois Filho, Cristina Bosetti(Joint Research Centre), Tatiana V. Macfarlane(University Dental Hospital of Manchester), Kirsten Moysich(Roswell Park Comprehensive Cancer Center), Heribert Ramroth(Heidelberg University), Gwenn Menvielle(Inserm), Claire M. Healy(Broad Institute), Carlo La Vecchia(University of Milan), F. Merletti(Department of Medical Sciences), Maura L. Gillison(The University of Texas MD Anderson Cancer Center), Hermann Brenner(Universidad de Granada), Vijayvel Jayaprakash(Roswell Park Comprehensive Cancer Center), Otávio Alberto Curioni(Hospital Heliópolis), Kristina Kjærheim(Cancer Registry of Norway), María Paula Curado(AC Camargo Hospital), Alexander W. Daudt(Hospital de Clínicas de Porto Alegre), Rolando Herrero(Centre international de recherche sur le cancer), Pagona Lagiou(National and Kapodistrian University of Athens), Joshua Muscat(Penn State Milton S. Hershey Medical Center), Chu Chen(Fred Hutch Cancer Center), Leticia Fernandez(Instituto de Oncología y Radiobiología), Heiko Müller(Mario Negri Institute for Pharmacological Research), Sergio Koifman(Escola Nacional de Saúde Pública), Philip Lazarus(Washington State University Spokane), Elena Matos(Universidad de Buenos Aires), Xavier Castellsagué(Queen Mary University of London), Hal Morgenstern(University of Michigan), A.F. Olshan(University of North Carolina at Chapel Hill), Karl Kelsey(Brown University), Fabio Levi(University Hospital of Lausanne), L.M.D. Macpherson(University of Glasgow), Jolanta Lissowska, Eleonora Fabianova(Public Health Authority of the Slovak Republic), Danièle Luce
Cited by 165
Related Papers
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.1k
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
|Journal of Clinical Oncology|2011|3.6k